top of page

A673 Xenograft Model

Rincon Bio offers efficacy studies using the A673 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Sarcoma
Derivation:
Muscle cell tissue of a 15yo female Ewings Sarcoma patient, originally thought to be a rhabdomyosarcoma
Mutations:
BRAF, TP53, EWS-FLI1 fusion
NCI60:
No
Weeks from stratification to termination (average):
3

A673 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the A673 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page